OUR TEAM

Expertise dedicated to facilitating and accelerating the delivery of image-driven ophthalmic innovations to the clinic.

Translational Imaging Innovations, Inc. (TII) was founded by Eric Buckland, Ph.D., co-founder and CEO of OCT innovator Bioptigen. TII was formed directly as a response to opportunity and challenges of translational imaging in ophthalmology observed during his Bioptigen tenure.

Team

Eric Buckland, PhD

CEO

Maureen Tuffnell, MS

Product Manager

Rob Williams, MBA

CTO

Tammy Carrea

Regulatory Affairs

Andrew Witchger

Senior Engineer

Taylor Szeto

Product Engineer

ADVISORS

Joseph Carroll, PhD

Chief Science Advisor

Brad Fortner, PhD

DATA Science Advisor

Rob Cooper, PhD

Biomarker Scientist

Brandon Lujan, MD

Chief Medical Advisor